The novel/atypical neuroleptics have proven to be effective in treating negative symptoms but although clinical experience appears to show that they have advantages over the traditional neuroleptics in treating negative symptoms, superiority has not always been statistically confirmed and the treatment results in individual patients in everyday clinical practice are often not satisfying. Therefore other drug treatment options also have to be carefully considered.